Stefano Savonitto Selected Research

reteplase

10/2009	1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.
5/2008	Facilitated PCI in patients with ST-elevation myocardial infarction.
2/2008	Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
11/2002	Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Savonitto Research Topics

Disease

40	Acute Coronary Syndrome 02/2022 - 01/2002
35	Hemorrhage 02/2022 - 03/2008
33	Myocardial Infarction 02/2022 - 03/2002
22	ST Elevation Myocardial Infarction 01/2022 - 09/2003
18	Stroke (Strokes) 02/2022 - 12/2006
15	Thrombosis (Thrombus) 01/2022 - 07/2012
11	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 03/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
7	Heart Failure 01/2021 - 01/2002
6	Cardiogenic Shock 10/2021 - 10/2008
5	Infarction (Infarctions) 01/2022 - 03/2002
4	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 04/2008
4	COVID-19 01/2022 - 12/2020
4	Renal Insufficiency (Renal Failure) 01/2020 - 02/2016
4	Non-ST Elevated Myocardial Infarction 01/2020 - 09/2003
4	Diabetes Mellitus 02/2019 - 01/2014
3	Chronic Renal Insufficiency 02/2022 - 02/2019
3	Shock 01/2020 - 10/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 01/2002
3	Thrombocytopenia (Thrombopenia) 01/2017 - 08/2005
2	Atherosclerosis 01/2022 - 06/2018
2	Infections 10/2021 - 04/2016
2	Coronary Disease (Coronary Heart Disease) 06/2020 - 02/2005
2	Hypertension (High Blood Pressure) 01/2020 - 01/2002
2	Frailty 01/2020 - 02/2019
2	Anemia 01/2018 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2017
1	Coronary Restenosis 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Thromboembolism 07/2021
1	Heart Injuries 07/2021
1	Low Cardiac Output 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Heart Arrest (Cardiac Arrest) 10/2020
1	Ischemic Colitis 08/2020
1	Cardiomyopathies (Cardiomyopathy) 06/2020
1	Atrial Fibrillation 06/2020
1	Peripheral Arterial Disease 06/2020
1	Body Weight (Weight, Body) 01/2020
1	Hypercholesterolemia 01/2020
1	Overweight 01/2020
1	Heart Diseases (Heart Disease) 03/2019
1	Drug-Related Side Effects and Adverse Reactions 02/2019

Drug/Important Bio-Agent (IBA)

10	Clopidogrel (Plavix)FDA Link 01/2022 - 02/2005
9	Prasugrel Hydrochloride FDA Link 01/2022 - 02/2010
8	Glycoproteins (Glycoprotein)IBA 01/2022 - 02/2006
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 02/2008
7	TicagrelorIBA 01/2022 - 11/2011
7	Abciximab (ReoPro)FDA Link 01/2015 - 02/2002
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 10/2016
5	Pharmaceutical PreparationsIBA 08/2017 - 02/2005
4	CreatinineIBA 01/2021 - 03/2008
4	AnticoagulantsIBA 06/2020 - 05/2011
4	Tirofiban (Aggrastat)FDA Link 01/2020 - 07/2012
4	bivalirudin (Angiomax)FDA Link 08/2017 - 05/2011
4	Heparin (Liquaemin)FDA LinkGeneric 08/2017 - 02/2002
4	reteplase FDA Link 10/2009 - 11/2002
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 07/2014
3	Creatine Kinase (Creatine Phosphokinase)IBA 12/2017 - 01/2002
3	Eptifibatide (Integrilin)FDA Link 05/2014 - 07/2012
3	EnzymesIBA 03/2002 - 01/2002
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2020
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 11/2011
2	omega-Chloroacetophenone (Mace)IBA 10/2020 - 01/2017
2	DiureticsIBA 06/2020 - 01/2020
2	aleglitazarIBA 01/2018 - 01/2017
2	Platelet Membrane GlycoproteinsIBA 11/2002 - 03/2002
1	MB Form Creatine KinaseIBA 01/2022
1	CD40 Ligand (CD40L)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2021
1	TroponinIBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	pro-brain natriuretic peptide (1-76)IBA 07/2021
1	fibrin fragment D (D-dimer)IBA 07/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	Vitamin K FDA Link 06/2020
1	Factor Xa InhibitorsIBA 06/2020
1	RivaroxabanIBA 06/2020
1	Therapeutic UsesIBA 02/2019
1	APTIBA 02/2019
1	Estrogens (Estrogen)FDA Link 06/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018

Therapy/Procedure

40	Therapeutics 01/2022 - 11/2002
35	Percutaneous Coronary Intervention 02/2022 - 03/2002
20	Stents 01/2022 - 02/2008
10	Patient Readmission 06/2020 - 03/2008
4	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 02/2016
4	Length of Stay 03/2015 - 09/2003
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2020 - 01/2018
2	Secondary Prevention 01/2022 - 12/2015
2	Critical Care (Surgical Intensive Care) 12/2020 - 01/2020
2	Drug-Eluting Stents 01/2020 - 02/2006
2	Conservative Treatment 09/2012 - 03/2008
2	Thrombolytic Therapy 02/2008 - 11/2002
1	Myocardial Revascularization 04/2020
1	Hysterectomy 01/2020
1	Estrogen Replacement Therapy 02/2018
1	Erythrocyte Transfusion 01/2018